Literature DB >> 9039934

Human monocytes activate porcine endothelial cells, resulting in increased E-selectin, interleukin-8, monocyte chemotactic protein-1, and plasminogen activator inhibitor-type-1 expression.

M T Millan1, C Geczy, K M Stuhlmeier, D J Goodman, C Ferran, F H Bach.   

Abstract

Monocytes (Mo) are thought to be important effector cells in early xenograft rejection. Effects of Mo-endothelial cell (EC) interactions on EC activation in vitro were studied by coculturing human Mo or human monocytoid cell lines, U937 and THP-1, with porcine EC. Without preactivation, U937 cells and Mo induced mRNA for the EC-specific adhesion receptor, E-selectin, expressed only on activated cells, after 2 hr. Surface protein was maximal when equal numbers of EC and Mo were cocultured. Increased mRNA expression of the chemokines, interleukin-8 and monocyte chemotactic protein-1, and the antifibrinolytic protein plasminogen activator inhibitor type-1, confirmed EC activation. Like E-selectin, plasminogen activator inhibitor type-1 mRNA was rapidly induced and returned to baseline after 24 hr, whereas chemokine gene expression was slower and more prolonged. Interleukin-1 receptor antagonist failed to modulate induction of E-selectin. Soluble tumor necrosis factor (TNF) alpha receptor inhibited E-selectin induced by TNF alpha, but not by U937 cells, and mRNA and protein on EC in Mo-EC mixtures cocultured at 1:1 ratios were not significantly reduced. The TNF alpha inhibitor did reduce E-selectin expression (30-40%), as well as induced chemokine gene expression (80%), at higher Mo-EC ratios. Despite this, minimal TNF alpha was detectable in supernatants. These results, along with the transwell experiments that confirmed a requirement for Mo-EC contact, suggest that membrane-bound TNF alpha may be involved. Thus, Mo-EC interactions in the porcine to human combination activated several EC functions, suggesting that initial Mo contact with the vessel wall of a xenogeneic graft may promote leukocyte recruitment, inflammation, and maintenance of thrombus, resulting in eventual organ destruction.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9039934     DOI: 10.1097/00007890-199702150-00016

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  6 in total

Review 1.  Xenotransplantation--2000.

Authors:  M J Goddard; J E Foweraker; J Wallwork
Journal:  J Clin Pathol       Date:  2000-01       Impact factor: 3.411

Review 2.  Mechanisms involved in antibody- and complement-mediated allograft rejection.

Authors:  Barbara A Wasowska
Journal:  Immunol Res       Date:  2010-07       Impact factor: 2.829

Review 3.  Progress in xenotransplantation: overcoming immune barriers.

Authors:  Megan Sykes; David H Sachs
Journal:  Nat Rev Nephrol       Date:  2022-10-05       Impact factor: 42.439

4.  Cytokine secretion depends on Galalpha(1,3)Gal expression in a pig-to-human whole blood model.

Authors:  Marit Saethre; Mårten K J Schneider; John D Lambris; Paola Magotti; Guttorm Haraldsen; Jörg D Seebach; Tom E Mollnes
Journal:  J Immunol       Date:  2008-05-01       Impact factor: 5.422

Review 5.  Hypoxia-like tissue injury as a component of multiple sclerosis lesions.

Authors:  Hans Lassmann
Journal:  J Neurol Sci       Date:  2003-02-15       Impact factor: 3.181

6.  Tumor-Associated Endothelial Cells Promote Tumor Metastasis by Chaperoning Circulating Tumor Cells and Protecting Them from Anoikis.

Authors:  Arti Yadav; Bhavna Kumar; Jun-Ge Yu; Matthew Old; Theodoros N Teknos; Pawan Kumar
Journal:  PLoS One       Date:  2015-10-28       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.